Monopar Therapeutics Inc. (MNPR) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ACXP, ADAG, ANEB, ANTX, AVTE and others.
MNPR has a market capitalization of $387.61M, compared to an average peer market cap of $252.42M. MNPR is significantly larger than its average peer.